BridgeMD
New treatment option for Cardiac Arrest
Official title Post-CA Neuroprotection With Magnesium
ClinicalTrials.gov ID: NCT06455514
What this study is testing
What is Magnesium Sulfate?
Magnesium Sulfate is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for cardiac arrest.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this pilot interventional study is to collect preliminary data on administering magnesium sulfate as a neuroprotective medication in patients who achieved Return of Spontaneous Circulation (ROSC) following Cardiac Arrest (CA). The primary aims are to assess the feasibility and safety of administering magnesium and measure serum markers of neuronal injury at prespecified time points in the post-cardiac arrest period.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Documented post-cardiac arrest patient with Return of Spontaneous Circulation (ROSC) achieved \<2 hours prior to recruitment
You likely can't join if
- Age \ 85 years
- Traumatic cardiac arrests
- Unsustained ROSC (\<20 minutes)
- Patient who is responsive/able to follow motor commands within 1 hour of achieving ROSC
- Plan for withdrawal of life support within 72 hours of ROSC
- Known pregnant women at the time of the cardiac arrest
See the full eligibility criteria
- Documented post-cardiac arrest patient with Return of Spontaneous Circulation (ROSC) achieved \<2 hours prior to recruitment
- Age \ 85 years
- Traumatic cardiac arrests
- Unsustained ROSC (\<20 minutes)
- Patient who is responsive/able to follow motor commands within 1 hour of achieving ROSC
- Plan for withdrawal of life support within 72 hours of ROSC
- Known pregnant women at the time of the cardiac arrest
- Known prisoners at the time of the cardiac arrest
- people who have a medical o social condition that would make them inappropriate for the study based on the PI's or clinical team judgement.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.